Pioglitazone improves myocardial blood flow and glucose utilization in nondiabetic patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled study

This study's aim was to examine whether treatment with pioglitazone, added to conventional lipid-lowering therapy, would improve myocardial glucose utilization (MGU) and blood flow (MBF) in nondiabetic patients with familial combined hyperlipidemia (FCHL). Thiazolidinediones were found to impro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2007-11, Vol.50 (21), p.2051-2058
Hauptverfasser:	Naoumova, Rossi P, Kindler, Heiko, Leccisotti, Lucia, Mongillo, Marco, Khan, Muhammad T, Neuwirth, Clare, Seed, Mary, Holvoet, Paul, Betteridge, John, Camici, Paolo G
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood Glucose - analysis Blood pressure Cardiology Cardiovascular disease Cholesterol Confidence intervals Coronary Circulation - drug effects Diabetes Double-Blind Method Drug Therapy, Combination Female Glucose Glucose - analysis Glucose - metabolism Heart - drug effects Heart attacks Humans Hyperlipidemia, Familial Combined - drug therapy Hypoglycemic Agents - pharmacology Hypoglycemic Agents - therapeutic use Hypolipidemic Agents - therapeutic use Insulin resistance Lipids Lipoproteins Male Middle Aged Positron-Emission Tomography Public access Studies Thiazolidinediones - pharmacology Thiazolidinediones - therapeutic use Treatment Outcome Triglycerides University colleges
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!